Clinical Use and Patentability of Cord Blood
Küçük Resim Yok
Tarih
2017
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Bentham Science Publ Ltd
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Background: The blood in the umbilical cord that provides the connection between mother and fetus during pregnancy is called cord blood. The blood of umbilical cord which is usually got rid of following birth, is a very rich stem cell source. Objective: Cord blood collection gives no harm to the mother and baby. Besides, its allogeneic and autologous usage, the most important disadvantage is that the number of cells is insufficient in adults. Conclusion: Today, it is predominantly used for therapeutic purposes for many diseases. The aim of this review is giving a detailed information about groups of stem cells in cord blood and determining the point of clinical use.
Açıklama
Anahtar Kelimeler
Clinical use, cord blood, stem cell, umblical cord blood, patent, haematology, haemopoetic diseases
Kaynak
Recent Patents on Endocrine Metabolic & Immune Drug Discovery
WoS Q Değeri
N/A
Scopus Q Değeri
N/A
Cilt
11
Sayı
1
